CURRENT AFFAIRS

Detailed explanation-1: -Convalescent plasma (kon-vuh-LES-unt PLAZ-muh) therapy uses blood from people who’ve recovered from an illness to help others recover. The U.S. Food and Drug Administration (FDA) has given emergency authorization for convalescent plasma therapy with high antibody levels to treat COVID-19 .

Detailed explanation-2: -Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial) | medRxiv.

Detailed explanation-3: -TREATMENT OF CORONAVIRUS DISEASE 2019 (COVID-19) Transfusion of COVID-19 convalescent plasma may benefit patients with COVID-19 and weakened immune systems.

Detailed explanation-4: -Plasma therapy involves introducing the blood plasma of a recovered coronavirus patient into the body of a patient who is presently affected by the virus. The plasma of the recovered person has antibodies present that were created by the immune system to fight the virus.

Detailed explanation-5: -Plasma Transfusions Plasma is the liquid part of the body’s blood. It contains important proteins and other substances crucial to one’s overall health. Plasma transfusions are used for patients with liver failure, severe infections, and serious burns.